Unbound MEDLINE

Fatal Hyperacute Graft-versus-Host Disease following Denileukin Diftitox Treatment for Recurrent T Cell Lymphoma after Allogeneic Stem Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] Journal article

 
TitleFatal Hyperacute Graft-versus-Host Disease following Denileukin Diftitox Treatment for Recurrent T Cell Lymphoma after Allogeneic Stem Cell Transplantation.
Author(s)Khubchandani S, Deeb G, Smiley SL, Battiwalla M, Paplham P, Brown K, Syta M, Hahn T, Cheney R, McCarthy PL, Hong F 
InstitutionRoswell Park Cancer Institute, SUNY Buffalo, Buffalo, NY.
SourceBiol Blood Marrow Transplant 2009 Jul; 15(7):887-90.
Languageeng
Pub Type(s)Letter
PubMed ID19539223
  
Advertise on this site.